1ELEVAN BIO
LIVE

Serial Number

99399472

Owner

1Elevan Biopharmaceuticals, Inc.

Attorney

Michael A. Geller

Filing Date

Sep 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

1ELEVAN BIO Trademark

Serial Number: 99399472

1ELEVAN BIO is a trademark filed by 1Elevan Biopharmaceuticals, Inc. on September 18, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

1Elevan Biopharmaceuticals, Inc.

12001 Exit 5 Parkway
Fishers, IN 46037

Entity Type: 03

Trademark Details

Filing Date

September 18, 2025

Registration Date

Not Registered

Published for Opposition

April 7, 2026

Goods & Services

Pharmaceuticals for the treatment of cardiovascular, respiratory, central nervous system, rheumatology diseases, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, hematology, tissue, organ, ocular, and kidney, urology, oncological, and bone diseases; synthetic peptides for pharmaceutical purposes

Laboratory services for biomanufacturing peptides; medical research; medical and pharmaceutical research in the field of peptides; scientific and medical research and design services in the field of peptides; information services in the field of pharmaceutical research and peptides

Mail order pharmacy services; database management services in the field of peptides, clinical trial information, and government regulatory information

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 2, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 2, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 2, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 18, 2025 MAFR
NEW APPLICATION ENTERED
Sep 18, 2025 NWAP